Inadequate quality of administration of intranasal corticosteroid sprays.

administration techniques allergic rhinitis intranasal corticosteroid sprays quality of administration

Journal

Journal of asthma and allergy
ISSN: 1178-6965
Titre abrégé: J Asthma Allergy
Pays: New Zealand
ID NLM: 101543450

Informations de publication

Date de publication:
2019
Historique:
entrez: 2 5 2019
pubmed: 2 5 2019
medline: 2 5 2019
Statut: epublish

Résumé

Considering the fact that many mistakes are still being made by asthmatic patients when inhaling lung medication, it is important to gain insight into current techniques used to administer intranasal corticosteroid sprays (INCS) in allergic rhinitis patients. In this study, we aimed to get insight into daily use of INCS and to determine if improvement of the technique is required. A checklist, based on available patient information leaflets (PILs) and literature, was used to determine the participants' application of the techniques used to administer INCS. These applied techniques were compared with steps described in PILs and recommended essential steps. In the overall population (64 participants) four participants (6%) carried out all steps as described in the PIL and seven participants (11%) carried out all recommended essential steps. The technique used to administer INCS is inadequate. Uniform and generally applicable instructions are needed and patients using INCS should be guided better.

Identifiants

pubmed: 31040706
doi: 10.2147/JAA.S189523
pii: jaa-12-091
pmc: PMC6452790
doi:

Types de publication

Journal Article

Langues

eng

Pagination

91-94

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Otolaryngol Head Neck Surg. 2004 Jan;130(1):5-24
pubmed: 14726906
Allergy. 2008 Apr;63 Suppl 86:8-160
pubmed: 18331513
Allergy. 2008 Oct;63(10):1301-9
pubmed: 18782108
Allergy. 2009 Jan;64(1):123-48
pubmed: 19132975
Chest. 2016 Aug;150(2):394-406
pubmed: 27060726
Cochrane Database Syst Rev. 2016 Apr 26;4:CD011996
pubmed: 27115217
Int Forum Allergy Rhinol. 2016 Nov;6(11):1204-1210
pubmed: 27315490
Curr Drug Metab. 2016;17(10):992-996
pubmed: 27890006
J Laryngol Otol. 2017 Nov;131(11):991-996
pubmed: 29050548
BMJ Open. 2019 Jan 15;9(1):e026710
pubmed: 30647049

Auteurs

Corine Rollema (C)

Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands, corinerollema@gmail.com.
Groningen Research Institute of Pharmacy, Department Pharmaco therapy, Epidemiology and Economy, University of Groningen, Groningen, The Netherlands, corinerollema@gmail.com.

Eric N van Roon (EN)

Department of Clinical Pharmacy and Pharmacology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands, corinerollema@gmail.com.
Groningen Research Institute of Pharmacy, Department Pharmaco therapy, Epidemiology and Economy, University of Groningen, Groningen, The Netherlands, corinerollema@gmail.com.

Tjalling W de Vries (TW)

Department of Paediatrics, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.

Classifications MeSH